These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7273703)

  • 21. Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression.
    Gómez-Gil E; Gastó C; Carretero M; Díaz-Ricart M; Salamero M; Navinés R; Escolar G
    Hum Psychopharmacol; 2004 Jun; 19(4):251-8. PubMed ID: 15181653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects.
    Karniol IG; Dalton J; Lader M
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):337-48. PubMed ID: 822990
    [No Abstract]   [Full Text] [Related]  

  • 23. Responses to tyramine and norepinephrine after imipramine and trazodone.
    Larochelle P; Hamet P; Enjalbert M
    Clin Pharmacol Ther; 1979 Jul; 26(1):24-30. PubMed ID: 376211
    [No Abstract]   [Full Text] [Related]  

  • 24. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 25. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of venlafaxine, trazodone, and placebo in major depression.
    Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
    J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL; Moeller FG
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of tetracyclic and tricyclic antidepressants on the serotonin uptake by human thrombocytes in vitro.
    Rysánek K; Benesová O; Spánková H
    Act Nerv Super (Praha); 1974; 16(4):307-8. PubMed ID: 4451016
    [No Abstract]   [Full Text] [Related]  

  • 30. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
    Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of antidepressive agents on serotonin secretion and membrane potential changes in thrombocytes].
    Pogady J
    Psychiatr Neurol Med Psychol (Leipz); 1983 Jun; 35(6):353-6. PubMed ID: 6635026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trazodone in the treatment of neurotic depression.
    Goldberg HL; Finnerty RJ
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):430-4. PubMed ID: 7440519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.
    Bakish D; Ravindran A; Hooper C; Lapierre Y
    Psychopharmacol Bull; 1994; 30(1):53-9. PubMed ID: 7972630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of serotonin uptake by human thrombocytes and inhibition of thrombocyte aggregation. Comparison of the effect of octoclothepine and chlorpromazine and tricyclic antidepressants.
    Spánková H; Rysánek K; Růzicková S
    Act Nerv Super (Praha); 1972; 14(2):133-4. PubMed ID: 5040165
    [No Abstract]   [Full Text] [Related]  

  • 36. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.
    Odagaki Y; Toyoshima R; Yamauchi T
    J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents.
    Axelson DA; Perel JM; Birmaher B; Rudolph G; Nuss S; Yurasits L; Bridge J; Brent DA
    Am J Psychiatry; 2005 Apr; 162(4):802-4. PubMed ID: 15800159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serotonin transport by blood platelets of depressive patients].
    Modai I; Aizenberg D; Hermesh H
    Harefuah; 1986 Jan; 110(2):64-7. PubMed ID: 3699599
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet serotonin uptake in depressed patients: circadian effect.
    Rausch JL; Shah NS; Burch EA; Donald AG
    Biol Psychiatry; 1982 Jan; 17(1):121-3. PubMed ID: 7059634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.